DarioHealth Corp

NASDAQ DRIO

Data sourced from

and

Download Data

DarioHealth Corp Non-current Liabilities to Total Liabilities Ratio 3 year CAGR for the year ending December 31, 2023: 180.24%

DarioHealth Corp Non-current Liabilities to Total Liabilities Ratio 3 year CAGR is 180.24% for the year ending December 31, 2023, a 112.46% change year over year. The total non-current liabilities to total liabilities ratio measures the proportion of a company's non-current liabilities to its total liabilities. It is calculated by dividing the total non-current liabilities by the total liabilities. This ratio provides insights into the composition of a company's liabilities and the extent to which it relies on long-term debt and obligations. A higher ratio indicates a greater reliance on non-current liabilities, suggesting potential long-term financial commitments and increased financial risk. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

DarioHealth Corp Non-current Liabilities to Total Liabilities Ratio for the year ending December 31, 2022 was 0.51, a 810.94% change year over year.
DarioHealth Corp Non-current Liabilities to Total Liabilities Ratio for the year ending December 31, 2021 was 0.06, a 81.65% change year over year.
DarioHealth Corp Non-current Liabilities to Total Liabilities Ratio for the year ending December 31, 2020 was 0.03, a -61.84% change year over year.
DarioHealth Corp Non-current Liabilities to Total Liabilities Ratio for the year ending December 31, 2019 was 0.08, a 0.00% change year over year.

NASDAQ: DRIO

DarioHealth Corp

CEO	Mr. Erez Raphael
IPO Date	Oct. 6, 2014
Location	United States
Headquarters	18 West 18th Street, New York, NY, United States, 10011
Employees	276
Sector	Healthcare
Industry	Health information services

Description

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Key trends